Alumis (ALMS) Change in Accured Expenses (2023 - 2025)
Alumis (ALMS) reported Change in Accured Expenses of $3.5 million for Q4 2025, up 11.75% year-over-year from $3.1 million in Q4 2024, and up 187.42% quarter-over-quarter from -$4.0 million in Q3 2025.
Alumis (ALMS) Change in Accured Expenses (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Change in Accured Expenses data on file, last reported at $3.5 million in Q4 2025.
- Change in Accured Expenses for Q4 2025 came in at $3.5 million, up 11.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.0 million (up 70.41% YoY), and the FY2025 annual result was $6.0 million, up 70.41% from the prior year.
- Change in Accured Expenses improved to $3.5 million in Q4 2025 per ALMS's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $5.0 million in Q1 2025 and troughed at -$4.0 million in Q3 2025.
- A 3-year average of $1.2 million and a median of $1.6 million in 2023 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 255.29% in 2025 and fell as far as 270.36% in 2025.
- A 3-year view of Change in Accured Expenses shows it stood at $1.6 million in 2023, then surged by 91.64% to $3.1 million in 2024, then advanced by 11.75% to $3.5 million in 2025.
- Business Quant data shows ALMS's Change in Accured Expenses at $3.5 million in Q4 2025, -$4.0 million in Q3 2025, and $1.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 3.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.48 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | -3.98 Mn |
| Sep 30, 2025 | -3.98 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | -3.21 Mn |
| Mar 31, 2024 | -3.21 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.11 Mn |